Wedbush initiated coverage on TScan Therapeutics with a new price target

6/22/23 7:30:31 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Wedbush initiated coverage of TScan Therapeutics with a rating of Outperform and set a new price target of $8.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$TCRX

Date	Price Target	Rating	Analyst
5/16/2024	$12.00	Buy	BTIG Research
5/13/2024	$11.00	Buy	Needham
6/22/2023	$8.00	Outperform	Wedbush
12/16/2021	$21.00	Buy	HC Wainwright & Co.
8/13/2021		Outperform	Cowen & Co.
8/10/2021	$22.00	Overweight	Barclays
8/10/2021	$22.00	Overweight	Morgan Stanley
8/10/2021	$21.00	Buy	Jefferies